Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12110339 ICOS ligand variant immunomodulatory proteins and uses thereof

Patent 12110339 was granted and assigned to ALPINE IMMUNE SCIENCES, INC. on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Oct, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 9 Oct, 2024
Edits made to:
Infobox (+62 properties)
Article (+319 characters)
‌

 US Patent 12110339 ICOS ligand variant immunomodulatory proteins and uses thereof

Article

Patent abstract

Provided herein are immunomodulatory proteins comprising ICOSL variants and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
ALPINE IMMUNE SCIENCES, INC.
0
Current Assignee
‌
ALPINE IMMUNE SCIENCES, INC.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
121103390
Patent Inventor Names
Michael Kornacker0
Ryan Swanson0
Date of Patent
October 8, 2024
0
Patent Application Number
171038070
Date Filed
November 24, 2020
0
Patent Citations
‌
US Patent 11078282 CD80 variant immunomodulatory proteins and uses thereof
0
‌
US Patent 7125717 Metabolically activated recombinant viral vectors and methods for their preparation and use
0
‌
US Patent 7153510 Recombinant vesiculoviruses and their uses
0
‌
US Patent 7172893 Virus vectors and methods of making and administering the same
0
‌
US Patent 7238526 Methods and cell line useful for production of recombinant adeno-associated viruses
0
‌
US Patent 7241447 Adeno-associated virus vectors and uses thereof
0
‌
US Patent 7247615 Peptide agonists of prostate-specific antigen and uses therefor
0
‌
US Patent 7332581 Polypeptide variants with altered effector function
0
‌
US Patent 7368116 Method of enhancing a targeted immune response against tumors
0
‌
US Patent 7371826 Polypeptide variants with altered effector function
0
‌
US Patent 7378087 Method of enhancing an immune response
0
‌
US Patent 7521532 GL50 polypeptides
0
‌
US Patent 7537924 Virus strains
0
‌
US Patent 7550296 Generation of replication competent viruses for therapeutic use
0
‌
US Patent 7588767 Microorganisms for therapy
0
‌
US Patent 7588771 Microorganisms for therapy
0
‌
US Patent 7612170 Co-stimulatory polypeptides
0
‌
US Patent 7619078 Nucleic acid molecules encoding B7-1
0
‌
US Patent 7662398 Microorganisms for therapy
0
‌
US Patent 7662627 Adeno-associated virus materials and methods
0
‌
US Patent 7709214 Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1
0
‌
US Patent 7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
0
‌
US Patent 7731974 Mutant vesicular stomatitis viruses and uses thereof
0
‌
US Patent 7754221 Microorganisms for therapy
0
‌
US Patent 7811814 Tetracycline-regulated adeno-associated viral (AAV) vectors for gene delivery to the nervous system
0
‌
US Patent 7897146 Treatment using herpes simplex virus
0
‌
US Patent 7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
0
‌
US Patent 7927585 Production of recombinant AAV virions
0
‌
US Patent 7943374 Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb
0
‌
US Patent 7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
0
‌
US Patent 8007780 AAV vectors for gene delivery to the lung
0
‌
US Patent 8624010 Nucleic acids encoding B7RP1
0
‌
US Patent 8709417 Combination immunotherapy for the treatment of cancer
0
‌
US Patent 8911726 Stabilized human Igg4 antibodies
0
‌
US Patent 8956619 Soluble CD80 as a therapeutic to reverse immune supression in cancer patients
0
‌
US Patent 9029315 Soluble PD-1 variants, fusion constructs, and uses thereof
0
‌
US Patent 9103831 Orally administered bacteria as vehicles for systemic delivery of agents
0
‌
US Patent 9375475 Combination immunotherapy for the treatment of cancer
0
‌
US Patent 9453227 Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
0
‌
US Patent 9546207 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
0
‌
US Patent 9834604 Inhibitors of T-cell activation
0
‌
US Patent 10858451 Bispecific antibodies that bind to CD38 and CD3
0
‌
US Patent 10882914 ICOS ligand variant immunomodulatory proteins and uses thereof
0
‌
US Patent 11319359 Immunomodulatory proteins with tunable affinities
0
‌
US Patent 6855317 Immunological herpes simplex virus antigens and methods for use thereof
0
‌
US Patent 6887471 Method to inhibit T cell interactions with soluble B7
0
‌
US Patent 6897045 Adeno-associated virus vectors
0
‌
US Patent 6936257 Recombinant Venezuelan equine encephalitis virus vaccine
0
‌
US Patent 6998252 Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences
0
‌
US Patent 7001765 Adeno-associated virus vector for boosting immunogenicity of cells
0
‌
US Patent 7033826 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
0
Patent Primary Examiner
‌
Ilia I Ouspenski
0

Find more entities like US Patent 12110339 ICOS ligand variant immunomodulatory proteins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo